Within the peer analysis summary, vital metrics for Agios Pharmaceuticals, Recursion Pharmaceuticals and Apellis ...

The current political climate in the U.S. played at least a moderate role in the increase in applicants to U.S. law schools, according to a Kaplan survey.

If language is what makes us human, what does it mean now that large language models have gained “metalinguistic” abilities?

Recursion uses artificial intelligence to help advance drug discovery, which could be a massive opportunity in healthcare.

If you're an artist doing retro-style work (or you dream of getting started) and you'd like to do more with your Linux ...

It's a plot device beloved by science fiction: our entire universe might be a simulation running on some advanced ...

Threat actors refine tactics with DNS attacks, new RATs, and Rust-based malware. Stay ahead with this week’s top ThreatsDay ...

With the rise in adoption of agentic AI by companies for automation and increasing complexities of the newer versions, ...

Debt Management: Agios Pharmaceuticals's debt-to-equity ratio is below the industry average. With a ratio of 0.04, the company relies less on debt financing, maintaining a healthier balance between ...

In this week’s edition of InnovationRx, we look Nvidia’s collaborations in life sciences and drug development, Cobot’s ...

Recursion, Roche, and its Genentech subsidiary have unveiled a whole-genome map of specialized microglial immune cells that they plan to use toward revealing significant new targets in ...

Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today it will provide business updates and report its third quarter 2025 ...